Nippon India Nifty Pharma ETF-Growth
Equity: Sectoral-Pharma - Growth (Open ended)
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: NIFTY Pharma Total Return IndexCheck Portfolio Overlap →
₹27.5+0.49%
18 Sept 2026
Tracking Difference
Annualised return gap between Nippon India Nifty Pharma ETF-Growth and its benchmark index over 1Y, 3Y, 5Y and 10Y periods, compared to the average of all funds tracking the same benchmark.
| Name | 1 Y | 3 Y | 5 Y | 10 Y |
|---|---|---|---|---|
| Fund | -0.31% | -0.31% | -0.27% | - |
| Avg. of funds with same benchmark | -0.31% | -0.31% | -0.27% | - |
Rolling Returns Analysis
Rolling annualized returns of Nippon India Nifty Pharma ETF-Growth across 1Y, 3Y and 5Y windows — average, best, worst returns and percentage of positive return periods.
| Metric | 1 Yr Rolling Returns | 3 Yr Rolling Returns | 5 Yr Rolling Returns | 7 Yr Rolling Returns |
|---|---|---|---|---|
| Analysis period | 08 Jul, 2022 - 18 Sep, 2026 | 19 Jul, 2024 - 18 Sep, 2026 | 27 Jul, 2026 - 18 Sep, 2026 | - |
| Average returns | 16.82% | 20.39% | 13.79% | - |
| Standard deviation | 21.62% | 2.98% | 0.48% | - |
| Best returns | 64.12% 1 year ending on 11 Mar, 2024 | 26.24% 3 years ending on 27 May, 2026 | 14.82% 5 years ending on 09 Sep, 2026 | - |
| Worst returns | -14.86% 1 year ending on 26 Jul, 2022 | 12.68% 3 years ending on 19 Jul, 2024 | 12.90% 5 years ending on 27 Jul, 2026 | - |
| Period with positive return | 71.77% | 100.00% | 100.00% | - |
| Period with return > 5% | 64.55% | 100.00% | 100.00% | - |
| Period with return > 10% | 57.32% | 100.00% | 100.00% | - |
| Period with return > 15% | 44.99% | 97.22% | 0.00% | - |
| Beat % Category | 35.26% | 27.64% | 35.90% | - |
| Beat % Benchmark | 38.82% | 21.52% | 30.77% | - |
Trailing Returns
Point-to-point returns of Nippon India Nifty Pharma ETF-Growth vs category average for YTD, 1M, 6M, 1Y, 3Y, 5Y and 10Y periods — with category rank and total funds count.
0%
10%
20%
30%
40%
18.0%
17.8%
18.2%
YTD
1.3%
0.9%
1.3%
1 M
18.3%
20.1%
18.4%
6 M
18.7%
15.0%
19.0%
1 Y
20.3%
20.8%
46.4%
3 Y
13.8%
14.0%
14.1%
5 Y
13.6%
9.3%
10 Y
Fund
Equity: Sectoral-Pharma
NIFTY Pharma Total Return Index
| Name | YTD | 1 M | 6 M | 1 Y | 3 Y | 5 Y | 10 Y | Since Inception |
|---|---|---|---|---|---|---|---|---|
| Fund | 18.01% | 1.31% | 18.28% | 18.74% | 20.35% | 13.76% | - | 12.97% |
| Equity: Sectoral-Pharma | 17.80% | 0.87% | 20.05% | 14.98% | 20.76% | 14.02% | 13.64% | - |
| NIFTY Pharma Total Return Index | 18.23% | 1.32% | 18.44% | 19.04% | 46.44% | 14.05% | 9.30% | - |
| Rank in category | 13 | 5 | 20 | 8 | 7 | 6 | - | - |
| Funds in category | 30 | 33 | 33 | 29 | 18 | 13 | 4 | - |
Period Returns
Calendar-year, quarterly and monthly return history of Nippon India Nifty Pharma ETF-Growth. Toggle between bar chart and table view to analyse periodic performance trends.
Historical Performance
Track NAV movement and cumulative returns of Nippon India Nifty Pharma ETF-Growth across 1M, 6M, 1Y, 3Y, 5Y and since-inception periods. Compare SIP and lumpsum growth over time.
Compare performance with respect toAdd benchmark
Add benchmark
Frequently Asked Questions
What are the 1-year returns of Nippon India Nifty Pharma ETF-Growth?
Nippon India Nifty Pharma ETF-Growth has delivered a 1-year return of 18.74% as of 17 Sep 2026. During the same period, its benchmark NIFTY Pharma Total Return Index returned 19.04%. The fund has underperformed its benchmark over this period.
What are the 3-year returns of Nippon India Nifty Pharma ETF-Growth?
Nippon India Nifty Pharma ETF-Growth has delivered a 3-year CAGR of 20.35% as of 17 Sep 2026. Its benchmark NIFTY Pharma Total Return Index returned 46.44% CAGR over the same period. CAGR (Compounded Annual Growth Rate) is the right way to evaluate multi-year ETF performance as it smooths out year-to-year volatility.
What are the 5-year returns of Nippon India Nifty Pharma ETF-Growth?
Nippon India Nifty Pharma ETF-Growth has delivered a 5-year CAGR of 13.76% as of 17 Sep 2026. Its benchmark NIFTY Pharma Total Return Index returned 14.05% CAGR over the same period. A 5-year track record is considered a more reliable indicator of fund quality than shorter-term performance, as it captures at least one full market cycle.
What are the returns of Nippon India Nifty Pharma ETF-Growth since inception?
Since its launch on 12 Jul 2021, Nippon India Nifty Pharma ETF-Growth has delivered a CAGR of 12.97%. Since-inception returns reflect the fund's full history and give the most complete picture of long-term performance.
How has Nippon India Nifty Pharma ETF-Growth performed vs its category over the long term?
Over the long term, Nippon India Nifty Pharma ETF-Growth has ranked 7 out of 18 funds in the Equity: Sectoral-Pharma category on a 3-year basis, and 6 out of 13 funds on a 5-year basis. Category rank is one of several factors to consider alongside risk metrics and rolling return consistency when evaluating a fund.
What is the Sharpe ratio of Nippon India Nifty Pharma ETF-Growth?
The Sharpe ratio of Nippon India Nifty Pharma ETF-Growth is 0.98 (as of 17 Sep 2026). The Sharpe ratio measures how much return the fund generates per unit of risk (volatility) taken. A Sharpe ratio above 1.0 is generally considered good — the higher the ratio, the better the risk-adjusted return.
What is the alpha of Nippon India Nifty Pharma ETF-Growth?
The 3Y alpha of Nippon India Nifty Pharma ETF-Growth is -0.06% (as of 17 Sep 2026). Alpha measures the excess return generated by the fund over and above its benchmark NIFTY Pharma Total Return Index, after adjusting for risk. A positive alpha means the fund manager has added value beyond what the market delivered. A negative alpha means the fund has underperformed its benchmark on a risk-adjusted basis.
What is the beta of Nippon India Nifty Pharma ETF-Growth?
The beta of Nippon India Nifty Pharma ETF-Growth is 0.94 (as of 17 Sep 2026). Beta measures how sensitive the fund is to market movements relative to its benchmark NIFTY Pharma Total Return Index. A beta of 1 means the fund moves in line with the market. A beta above 1 means it is more volatile than the market; below 1 means it is less volatile. Nippon India Nifty Pharma ETF-Growth's beta of 0.94 indicates it is more defensive than its benchmark.
What are the rolling returns of Nippon India Nifty Pharma ETF-Growth?
The average 1-year and 3-year rolling returns of Nippon India Nifty Pharma ETF-Growth is 16.82% and 20.39% respectively. Rolling returns show the fund's annualized return across every possible 1-year and 3-year investment window, making them a far more reliable measure of consistency than point-to-point returns, which depend heavily on the start and end date chosen.